Miltefosine

CAS No. 58066-85-6

Miltefosine( HePC )

Catalog No. M15130 CAS No. 58066-85-6

Miltefosine is used for the treatment of visceral and cutaneous leishmaniasis, and is undergoing clinical trials for this use in several other countries.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 42 In Stock
100MG 50 In Stock
200MG 77 In Stock
500MG 105 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Miltefosine
  • Note
    Research use only, not for human use.
  • Brief Description
    Miltefosine is used for the treatment of visceral and cutaneous leishmaniasis, and is undergoing clinical trials for this use in several other countries.
  • Description
    Miltefosine is used for the treatment of visceral and cutaneous leishmaniasis, and is undergoing clinical trials for this use in several other countries. Several medical agents have some efficacy against visceral or cutaneous leishmaniasis, however a 2005 survey concluded that miltefosine is the only effective oral treatment for both forms of leishmaniasis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    HePC
  • Pathway
    Angiogenesis
  • Target
    PKC
  • Recptor
    PKC
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    58066-85-6
  • Formula Weight
    407.58
  • Molecular Formula
    C21H46NO4P
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 82 mg/mL (201.19 mM); Water: 82 mg/mL (201.19 mM)
  • SMILES
    O=P(OCCCCCCCCCCCCCCCC)([O-])OCC[N+](C)(C)C
  • Chemical Name
    hexadecyl (2-(trimethylammonio)ethyl) phosphate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Uberall F, et al. Y Res, 1991, 51(3), 807-812.
molnova catalog
related products
  • Phorbol 12,13-dibuty...

    Phorbol 12,13-dibutyrate (Phorbol dibutyrate) is a PKC activator that inhibits α1-adrenoceptor-mediated positive inotropic effects in a concentration-dependent manner, induced by contraction of isolated rabbit vascular smooth muscle.

  • PKC β pseudosubstrat...

    Selective cell-permeable peptide inhibitor of protein kinase C (IC50 ~ 0.5 μM). Consists of amino acids 19 - 31 of PKC pseudosubstrate domain linked by a disulphide bridge to a cell permeabilisation Antennapedia domain vector peptide. The Antennapedia peptide is actively taken up by intact cells, at 4 or 37°C, ensuring rapid and effective uptake of the inhibitor peptide. Once inside the cell, the disulphide bonds are subjected to reduction in the cytoplasm leading to release of the inhibitor peptide.

  • Miltefosine

    Miltefosine is used for the treatment of visceral and cutaneous leishmaniasis, and is undergoing clinical trials for this use in several other countries.